(Press-News.org) INDIANAPOLIS -- An Indiana University cancer researcher and his colleagues have discovered new therapeutic targets and drugs that may someday benefit people with certain types of leukemia or blood cancer.
Reuben Kapur, Ph.D., the Frieda and Albrecht Kipp Professor of Pediatrics at the IU School of Medicine and a researcher at the Indiana University Melvin and Bren Simon Cancer Center, and colleagues discovered in pre-clinical and pharmacological models that cancer cells with a mutation in the KIT receptor -- an oncogenic/cancerous form of the receptor -- in mast cell leukemia and acute myeloid leukemia can be stopped.
Their findings were published online Sept. 16 in the Journal of Clinical Investigation and appeared in print Oct. 1.
According to Dr. Kapur, activating mutations of KIT receptors are almost always associated with a type of leukemia called mast cell leukemia. The mutations in the KIT receptor are found in about 90 percent of patients with this type of leukemia. In addition, activating mutations of KIT are also exclusively associated with a subtype of acute myeloid leukemia known as core binding factor leukemia. When KIT is associated with these two types of leukemia, the survival rate for patients is profoundly reduced in comparison to patients who do not have this mutation.
Dr. Kapur and colleagues investigated whether they could shut down the growth response that is induced by this mutation.
"We identified two new targets in leukemic cells bearing this mutation, which when targeted or inhibited, cause leukemia cells to die," Dr. Kapur said.
The researchers discovered that the two targets are Rac GTPase and Pak (p21-activated kinase). In return, they designed a novel Rac inhibitor -- EHop-016 -- that is considerably more potent than previously described inhibitors of Rac. They also demonstrated a novel role for Pak inhibition in leukemia using an existing Pak inhibitor.
Both are being tested in pre-clinical models to further examine their growth inhibitory properties as well as long-term treatment-associated toxicity.
Dr. Kapur said treatments for leukemia have remained mostly unchanged in the past 30 years. Thus, researchers continue to search for better and more effective ways to treat this debilitating disease.
"We've been looking for new targets and new ways of treating leukemia and special types of leukemias," Dr. Kapur said.
"Leukemia is an extremely complex disease. It's a combination of multiple alterations in the patient's DNA, which eventually results in leukemia. Therefore, it will be very difficult to cure leukemia with just one drug. It will have to be a combination of multiple drugs, if we're to cure this disease."
Dr. Kapur is also professor of biochemistry and molecular biology, of medical and molecular genetics, and of microbiology and immunology at the IU School of Medicine.
Principal authors of the study were Suranganie Dharmawardhane and Cornelis P. Vlaar of the Department of Pharmaceutical Sciences at the University of Puerto Rico; Ramon V. Tiu and Valeria Visconte of the Taussig Cancer Institute, Cleveland Clinic; Ray R. Mattingly of Wayne State University; Joydeep Gosh, Emily Sims, Baskar Ramdas, Anindya Chatterjee, Raghuveer Singh Mali and Holly Martin of the IU Department of Pediatrics, Herman B Wells Center for Pediatric Research; and Veerendra Munugalavadla of the Department of Cancer Immunotherapy and Hematology, Genentech Inc.
INFORMATION:
This study was supported, in part, by grants from the National Institutes of Health (R01HL077177, R01HL075816 and R01CA134777 to R. Kapur), F31AG040974 (to H. Martin) and T32HL007910 (to A. Chatterjee); a grant from the American Cancer Society (PF13-065-01 to A. Chatterjee); and a grant from Riley Children's Foundation (to R. Kapur).
END
HOUSTON – Children of melanoma survivors were more likely to wear hats and re-apply sunscreen after receiving a multi-media informational program designed specifically for them. These new findings were included in research published in the journal of Cancer Epidemiology, Biomarkers and Prevention – a publication of the American Association for Cancer Research.
A team of researchers led by Ellen R. Gritz, Ph.D., and Mary Tripp, Ph.D., M.P.H., both researchers of Behavioral Science at The University of Texas MD Anderson Cancer Center, conducted a randomized trial to determine ...
WASHINGTON, D.C. Oct. 4, 2013 -- Researchers in Japan have developed a new photodiode that can detect in just milliseconds a certain type of high-energy ultraviolet light, called UVC, which is powerful enough to break the bonds of DNA and harm living creatures. The researchers describe their new device in the journal Applied Physics Letters.
Although this radiation doesn't normally reach the Earth's surface, it can leak through to just below the hole in the ozone layer. Monitoring this radiation is a way of tracking the hole in the ozone layer, and photodiodes that measure ...
University of Notre Dame researchers Shahriar Mobashery and Mayland Chang and their collaborators in Spain have published research results this week that show how methicillin-resistant Staphylococcus aureus (MRSA) regulates the critical crosslinking of its cell wall in the face of beta-lactam antibiotics.
The work, published in the Proceedings of the National Academy of Sciences, reveals the mechanistic basis for how the MRSA bacterium became such a difficult pathogen over the previous 50 years, in which time it spread rapidly across the world. Modern strains of MRSA ...
Understanding how genes act in specific tissues is critical to our ability to combat many human diseases, from heart disease to kidney failure to cancer. Yet isolating individual cell types for study is impossible for most human tissues.
A new method developed by researchers at Princeton University and the University of Michigan called "in silico nano-dissection" uses computers rather than scalpels to separate and identify genes from specific cell types, enabling the systematic study of genes involved in diseases.
The team used the new method to successfully identify ...
Philadelphia, Pa. (October 4, 2013) – Doctors who abuse prescription drugs often do so for "self-medication"—whether for physical or emotional pain or stress relief, reports a study in the October Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Based on focus groups with physicians in treatment for substance abuse, the findings lend "unique insights" into the reasons why doctors abuse prescription medications—as well as important ...
NASA's footage of the first moon landing promised a future of sci-fi heroism that never came to pass, according to a new study.
The paper, by Professor Steve Brown and Professor Martin Parker, of the University of Leicester's School of Management, and Dr Lewis Goodings, of the University of Roehampton, is published in the International Journal of Management Concepts and Philosophy.
The first moon landing is overwhelmingly remembered as an exciting and important turning point in world history, which continues to inspire space exploration projects to Mars and beyond today.
However, ...
SAN FRANCISCO – Swallowing pills containing a concentrate of fecal bacteria successfully stops recurrent bouts of debilitating Clostridium difficile (C. diff) infection by rebalancing the bacteria in the gut, suggests a study being presented at the IDWeek 2013™ meeting today.
Infection from C. diff bacteria is such a concern that the Centers for Disease Control and Prevention (CDC) named it one of the three most urgent threats in its recent landmark report on antibiotic resistance. C. diff sickens half a million Americans and kills 14,000 every year. C. diff infection ...
SAN FRANCISCO – A vast majority of people who see their doctors for sore throats or acute bronchitis receive antibiotics, yet only a small percentage should, according to analyses of two major national surveys being presented at IDWeek 2013™. Those illnesses usually are caused by viruses, and antibiotics – which only treat bacterial infections – do not help.
Harvard University researchers analyzed the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey and determined that doctors prescribed antibiotics in 60 percent of visits ...
SAN FRANCISCO – When patients with HIV are hospitalized for other conditions, such as a heart problem, surgery or complications of diabetes, mistakes are often made involving their complicated anti-retroviral therapy (ART) regimens. But those errors are more than twice as likely to be corrected when patients are seen by an infectious diseases (ID) physician, suggests a Cleveland Clinic study being presented at IDWeek 2013™ today.
Most patients with HIV are cared for by physicians with HIV expertise in the community, and when they are hospitalized for non-HIV conditions, ...
VIDEO:
In this video, scientists demonstrate how to deliver drugs to the mammary gland via nipple-injection.
Click here for more information.
On October 4, JoVE, the Journal of Visualized Experiments, will publish a new technique for breast cancer treatment and prevention—injection of therapeutics via the nipple. The procedure, demonstrated on mice, offers direct access to the most common origin of breast cancer, the milk ducts, and could be used to offer cancer therapy ...
